fbpx
In the Media

REUTERS: Avoid Biotechs, Buy Into India

By October 15, 2015 January 10th, 2019 No Comments

Biotech stocks are still too pricey, but India is a long-term buy, Jeff Tomasulo tells Reuters’ Fred Katyama.